Our Company

About Us

Tibotec (tee-bo-tek) Therapeutics was established in March 2003 as a division of Centocor Ortho Biotech Products, L.P.

Headquartered in Titusville, N.J., the organization is dedicated to providing innovative virology therapeutics that help healthcare professionals address serious unmet needs in people living with HIV. Our company is focused on sales, marketing and post-marketing clinical research, working closely with other companies focused on drug research and development.

In HIV, Tibotec Therapeutics currently markets anti-retroviral medications (click here for more information about our products). The company works closely with Tibotec Pharmaceuticals, which has several compounds in development.

Tibotec Therapeutics draws on the scientific expertise and resources of several organizations, including Tibotec Pharmaceuticals Ltd, Centocor Research & Development, Inc. and Johnson & Johnson Pharmaceuticals Research & Development, LLC, as well as partnerships with leading external academic institutions and biopharmaceutical companies.

Paralleling the company's commitment to addressing serious unmet medical needs, Tibotec Therapeutics is dedicated to supporting health care professionals, patients and caregivers with support programs and services that reflect high standards of business conduct and Our Credo values.

It is our commitment to workplace diversity that helps to fulfill our Credo Values, develops leadership, drives and enriches innovation and enhances our customer service. Our associates are the backbone of our business now and into the future.